Upstream Bio, Inc. (UPB) stock
UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.78−0.08 (-2.80%)
Close on Nov 13, 2026Market cap $152.26MP/E –Yield –
Upstream Bio total assets
Total assets on the balance sheet at the end of each period.
Upstream Bio's total assets was $245.99M at Sep 30, 2026. For fiscal 2025 it was $353.77M, down 26.6% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $353.77M | -26.6% |
| FY2024 | Dec 31, 2024 | $481.72M | +311.0% |
| FY2023 | Dec 31, 2023 | $117.20M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $245.99M | -37.1% |
| Q2 FY2026 | Jun 30, 2026 | $281.17M | -33.1% |
| Q1 FY2026 | Mar 31, 2026 | $318.05M | -30.3% |
| Q4 FY2025 | Dec 31, 2025 | $353.77M | -26.6% |
| Q3 FY2025 | Sep 30, 2025 | $391.20M | +68.1% |
| Q2 FY2025 | Jun 30, 2025 | $420.52M | +258.8% |
| Q1 FY2025 | Mar 31, 2025 | $456.17M | – |
| Q4 FY2024 | Dec 31, 2024 | $481.72M | – |
| Q3 FY2024 | Sep 30, 2024 | $232.70M | – |
| Q4 FY2023 | Dec 31, 2023 | $117.20M | – |
See a number that looks wrong?